Jeena Sikho Lifecare Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025 for approval of Audited Financial results for the financial year ended March 31, 2025 and declaration of Final Dividend of Rs. 5.47/- per share for the F.Y. 2024-25 subject to the approval of the shareholders in ensuing Annual General Meeting of the Company.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Jeena Sikho Lifecare Limited, at its meeting on May 16, 2025, approved the audited standalone financial results for the financial year ended March 31, 2025, along with an unmodified opinion from statutory auditors KRA & Co. Revenue from operations grew sharply to Rs. 46,907.19 lacs (up ~44.6% from Rs. 32,440.89 lacs in FY24). Profit after tax rose to Rs. 9,072.89 lacs versus Rs. 6,920.63 lacs in FY24, a growth of about 31%. Basic EPS stood at Rs. 36.50, up from Rs. 27.84 in the previous year. The Board also recommended a final dividend of Rs. 5.47 per equity share for FY 2024-25, subject to shareholder approval at the upcoming AGM.
Strong top-line growth of ~45% and healthy ~31% PAT growth signal robust business momentum, which should be viewed positively by investors. The final dividend declaration rewards shareholders, though it is subject to approval at the AGM. The clean (unmodified) audit opinion adds further comfort on the credibility of the numbers.